Balanced news tone
News Sentiment
PROGEN sentiment intelligence
Prostatype Genomics AB (publ) news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
50
Balanced news tone
3 relevant articles
Price is moving more forcefully than the current news tone suggests.
66/100 classification confidence.
directly relevant articles
high-authority source matches
+36.6% over one week, +68.9% over four weeks, trend inactive, and below fair value.
Prostatype Genomics AB Auditor Raises 'Going Concern' Doubt
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Primary event
Market update
66/100 classification
One-week reaction
36.6%
Price confirming higher
Trend fit
Trend inactive
68.9% over four weeks
Fair value
-96.8%
Below fair value
Value support
Sentiment Mix
Positive, neutral, negative
Positive
0
Neutral
3
Negative
0
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
marketscreener.com
Direct company coverage
Prostatype Genomics AB Auditor Raises 'Going Concern' Doubt
- Tone
- Neutral 50/100
- Event
- Balance sheet
- Published
- 31 May 2026 07:00
- Source
- marketscreener.com
marketscreener.com
Direct company coverage
Prostatype Genomics Updates on Medicare Reimbursement Process for Prostatype in United States
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 25 May 2026 07:00
- Source
- marketscreener.com
Nature
Direct company coverage
Validation of the Prostatype® P-score for predicting prostate cancer specific mortality in a multiethnic U.S. veterans cohort
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 Jan 2026 08:00
- Source
- Nature